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Abstract
The potential immunomodulatory role of microRNAs in small intestine of patients with acute
watery diarrhea caused by Vibrio cholerae O1 or enterotoxigenic Escherichia coli (ETEC)
infection was investigated. Duodenal biopsies were obtained from study-participants at the
acute (day 2) and convalescent (day 21) stages of disease, and from healthy individuals.
Levels of miR-146a, miR-155 and miR-375 and target gene (IRAK1, TRAF6, CARD10) and
11 cytokine mRNAs were determined by qRT-PCR. The cellular source of microRNAs in
biopsies was analyzed by in situ hybridization. The ability of V. cholerae bacteria and their
secreted products to cause changes in microRNA- and mRNA levels in polarized tight
monolayers of intestinal epithelial cells was investigated. miR-146a and miR-155 were
expressed at significantly elevated levels at acute stage of V. cholerae infection and
declined to normal at convalescent stage (P<0.009 versus controls; P = 0.03 versus conva-
lescent stage, pairwise). Both microRNAs were mainly expressed in the epithelium. Only
marginal down-regulation of target genes IRAK1 and CARD10 was seen and a weak cyto-
kine-profile was identified in the acute infected mucosa. No elevation of microRNA levels
was seen in ETEC infection. Challenge of tight monolayers with the wild type V. cholerae O1
strain C6706 and clinical isolates from two study-participants, caused significant increase in
miR-155 and miR-146a by the strain C6706 (P<0.01). One clinical isolate caused reduction
in IRAK1 levels (P<0.05) and none of the strains induced inflammatory cytokines. In con-
trast, secreted factors from these strains caused markedly increased levels of IL-8, IL-1β,
and CARD10 (P<0.001), without inducing microRNA expression. Thus, miR-146a and miR-
155 are expressed in the duodenal epithelium at the acute stage of cholera. The inducer is
probably the V. cholerae bacterium. By inducing microRNAs the bacterium can limit the
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innate immune response of the host, including inflammation evoked by its own secreted fac-
tors, thereby decreasing the risk of being eliminated.
Introduction
Vibrio cholerae O1 and Enterotoxigenic Escherichia coli (ETEC) are the predominant causes of
acute dehydrating diarrhea in developing countries such as Bangladesh where a large propor-
tion of cases requiring hospitalization are reported [1–4]. Both pathogens are non-invasive
and colonize the small intestine. Major virulence factors and inducers of diarrhea are the
secreted cholera toxin and heat-labile- and heat-stable enterotoxins in the case of V. cholerae
O1 and ETEC, respectively [2, 5]. At the acute stage of disease in V. cholerae infection an innate
immune response is seen at the epithelial lining and its vicinity in the small intestinal mucosa
involving accumulation of neutrophil granulocytes, increased production of inflammatory
mediators and anti-microbial peptides [6, 7].
MicroRNAs are non-coding, 19–25 nucleotides long, single stranded RNA molecules that
regulate inflammation at the post-transcriptional level [8–13]. Although microRNAs on aver-
age have the capacity to repress hundreds of target mRNAs, their action as immunomodula-
tors seems to be highly regulated [8, 14–16]. Two microRNAs shown to be highly involved in
the regulation of the acute inflammatory response after pathogen recognition through Toll-
like receptors (TLRs) are miR-146a and miR-155 [17]. Identified target genes for miR-146a in
immune cells are the cytoplasmic adapter molecules Interleukin(IL)-1 receptor-associated
kinase 1 (IRAK1) and Tumor necrosis factor(TNF) receptor-associated factor 6 (TRAF6), key
molecules in the signaling pathway of Nuclear factor κ-light-chain-enhancer of activated B
cells (NFκB) activation downstream of Myeloid differentiation primary response gene 88
(MyD88) after pathogen recognition through TLRs [8, 11, 18–20]. More recently, Caspase
recruitment domain family member 10 (CARD10) was identified as a target mRNA for miR-
146a upon NFκ B activation of human retinal endothelial cells [21].
Three microRNAs, i.e. miR-146a, miR-155 and miR-375, were shown to be involved in
inflammatory conditions of the human intestine. Interestingly, the expression pattern of these
microRNAs differed between the chronic inflammatory conditions Crohn’s colitis and ulcera-
tive colitis with significantly higher levels of miR-375 at the inflamed compared to non-
inflamed areas in Crohn’s colitis while miR-146a levels were higher at inflamed areas in ulcera-
tive colitis. Levels of miR-155 were significantly higher in inflamed compared to non-inflamed
areas in both diseases [22]. An important role of miR-375 in innate immunity was revealed
when it was shown that high levels of miR-375 promote differentiation of intestinal epithelial
cells into goblet cells, the producers of the protective mucus layer facing the gut lumen [23].
The potential role of these microRNAs in responses to enteropathogens of the human small
intestine is still scarcely investigated, particularly little is known about their role in the innate
immune response of the epithelial cells to bacterial attacks.
In the present study we investigated whether V. cholerae O1 and ETEC infection induce
expression of the microRNAs miR-146a, miR-155 and miR-375 in the duodenal mucosa and
whether these microRNAs might play a role in resolution of disease by negative regulation of
inflammation. Paired biopsies, collected at acute and convalescent stage of disease were ana-
lyzed for the expression of miR-146a, miR-155 and miR-375 and their known target genes.
The inflammatory status of the mucosa was accessed as expression levels of mRNAs for
selected cytokines and chemokines. We also investigated whether V. cholerae O1, either the
Induction of microRNAs in duodenal mucosa at acute stage of cholera
PLOS ONE | https://doi.org/10.1371/journal.pone.0173817 March 20, 2017 2 / 20
Swedish Research Council-Natural and Engineering
Sciences grant no. 2013-4522 to M-L.H. and grant
no. 2014-4401 to S.N.W., the TORNADO-project
within the 7th framework program theme, grant
agreement no. 222720-2 to M-L.H., the Fund for
Biotechnology-oriented Basic Science at Umeå
University to M-L.H., the Kempe Foundations grant
no. SMK-1454 to S.N.W., the Science Foundation
Ireland (SFI) to S.M. under grant no. SFI/12/RC/
2273 to APC Microbiome Institute, the Found of
Donations to the Medical Faculty, Umeå University
to M-L.H., and a combined medical practice- and
research fellowship from the County of
Va¨sterbotten to A.Z.. icddr,b is thankful to the
donors for their support to its research efforts.
icddr,b is also grateful to the Government of
Bangladesh, Canada, Sweden and the UK for
providing core/unrestricted support. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors declare that no
competing interests exist.
whole bacteria or the secreted products, can act as a causative agent for changes in levels of
these microRNAs and their known target genes in human intestinal epithelial cells. The results
show that miR-146a and miR-155 levels are significantly elevated in V. cholerae O1 infected
patients at acute stage of disease and localized mainly in the epithelium. Furthermore, live V.
cholerae O1 bacteria, but not their secreted products induced all three microRNAs in polarized
tight monolayers of intestinal epithelial cells.
Results
MicroRNAs miR-146a and miR-155 are expressed in duodenal
epithelium of V. cholerae O1 infected patients
To investigate whether the miRNAs miR-146a, miR-155 and miR-375 are induced by V. cho-
lerae O1 and ETEC infection, paired duodenal biopsies were collected from six V. cholerae O1
and four ETEC infected patients at acute stage (day-2) and convalescent stage (day-21 post-
onset of infection) of disease and compared to single biopsies of five healthy controls. The
expression levels of both miR-146a and miR-155 were significantly higher at acute stage of V.
cholerae O1 infection when compared to healthy controls (median relative quantity (RQ) 19.6
and 6.6 for miR-146a and miR-155, respectively; Fig 1) with parallel increase in levels of the
two microRNAs in each biopsy (r = 0.943, P = 0.017). Notably, no elevated levels were seen
for either of these microRNAs in patients with acute ETEC infection (Fig 1). Furthermore,
patients in convalescence from V. cholerae O1 and ETEC infections presented similar levels of
miR-146a and miR-155 levels when compared to controls (Fig 1). In contrast to miR-146a and
miR-155, the expression level of miR-375 was not significantly elevated either in V. cholerae
O1 or ETEC infected patients (Fig 1).
Since significantly elevated miR-146a and miR-155 levels were seen in patients with acute
V. cholerae O1 infection, we analyzed the levels in each patient in relation to disease activity,
i.e. in paired samples from acute and convalescent stage. As seen in Fig 2, miR-146a and miR-
155 expression levels were significantly higher at the acute stage when compared to the
Fig 1. Patients with Vibrio cholerae O1 infection at the acute stage show significantly increased levels of microRNAs miR-146a and miR-155.
Amounts of miR-146a, miR-155 and miR-375 were determined by real-time qRT-PCR in duodenal biopsies of patients with V. cholerae O1 infection (n = 6)
at the acute (Acute V. cholerae) and convalescent (Conv. V. cholerae) stages, patients with ETEC infection (n = 4) at the acute (Acute ETEC) and
convalescent (Conv. ETEC) stages and in healthy controls (Healthy; n = 5) and normalized to the amount of RNU48 in the respective sample (Δct).
Relative quantity (RQ) was calculated by the 2(-ΔΔct)-method with the microRNA/RNU48 Δct-value in the sample over the median microRNA/RNU48 Δct-
value of the healthy control group. Each patient group was analyzed for significant changes compared to the healthy controls using Kruskal-Wallis test with
Dunn’s correction for multiple comparisons. P-values for statistically significant differences are given.
https://doi.org/10.1371/journal.pone.0173817.g001
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convalescent stage and were decreased to a level similar to that of healthy individuals in each
patient after transition to the convalescent stage.
Since miR-146a and miR-155 have mostly been reported in innate immune cells, the cellu-
lar source of these microRNAs in the duodenal mucosa at acute stage of V. cholerae infection
was assessed by in situ hybridization using probes complementary to these two microRNAs.
Hybridization experiments showed that both miR-146a and miR-155 were highly detected in
the mucosa of patients with V. cholerae O1 infection at acute stage with no expression detected
in the mucosa from patients with V. cholerae O1 infection at convalescent stage, at acute or
convalescent stage of ETEC infection or in healthy controls (Fig 3A–3H). Notably, at the acute
stage of V. cholerae O1 infection the majority of the cells in the epithelium were positive for
miR-146a and miR-155 while only a few scattered positive cells were seen in the lamina pro-
pria (Fig 3A and 3E). The intensity of staining for these two microRNAs was comparable to
that of the positive control (compare Fig 3A, 3E and 3I). Overall, our data identified increased
expression levels of miR-146a and miR-155 in the duodenal epithelium of V. cholerae O1
infected patients at the acute stage of disease. Based on these findings, the subsequent experi-
ments were focused on this patient group.
Expression levels of mRNA for the miR-146a target genes IRAK1,
TRAF6 and CARD10 do not change with disease activity
The expression levels of mRNA for three miR-146a targets, namely IRAK1, TRAF6 and
CARD10 were analyzed in the duodenal biopsies collected pairwise from patients at acute and
convalescent stage of V. cholerae O1 infection. The results show that all three miR-146a target
genes were expressed at significant levels in duodenal samples of patients at acute stage of dis-
ease (S1 Table). However, there was no significant difference in their expression levels when
these samples were compared to samples from the convalescent stage of disease (Fig 4 and
Fig 2. miR-146a and miR-155 levels decrease at the convalescent stage in patients with V. cholerae O1 infection. Relative quantities (RQ) of miR-
146a, miR-155 and miR-375 in duodenal biopsies of patients with V. cholerae O1 infection (n = 6) in the actue (Acute) and convalescent (Convalescent)
state of disease were calculated by the 2(-ΔΔct)-method with the microRNA/RNU48 Δct-value in the sample over the median microRNA/RNU48 Δct-value
of the healthy control group as reference. Lines connect the RQ-values at acute and convalescent stage of the same patient. Significance of differences
between Δct-values at acute and convalescent stage was analyzed using two-sided Wilcoxon’s non-parametric test for paired samples. P-values for
statistically significant differences are given.
https://doi.org/10.1371/journal.pone.0173817.g002
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Table 1; P>0.05). Still the expression levels of IRAK1, TRAF6 and CARD10 showed the
expected increase at convalescent stage in 2, 3 and 4 patients, respectively (Table 2).
The acute stage of V. cholerae infection induces an epithelial innate
immune response
To investigate the degree of a potential immune response induced by V. cholerae O1 bacteria
in the duodenal mucosa, expression levels of mRNA for the pro-inflammatory cytokines inter-
feron(IFN)-γ, IL-17A, TNF-α, and IL-6; the inflammasome cytokines IL-1β and IL-18; and the
immune cell attracting chemokines IL-8, CXCL9, CXCL10, CXCL11 and CX3CL1 were
Fig 3. miR-146a and miR-155 are expressed in the epithelium and lamina propria of duodenal mucosa in patients with V. cholerae O1 infection
at the acute stage. In situ hybridization was performed on sections of frozen duodenal mucosa using digitonin-labeled locked nucleic acid (LNA)
microRNA detection probes. Micrographs are representative of miR-146a (A—D) and miR-155 (E—H) staining of duodenal mucosa from one patient with
V. cholerae O1 infection at acute (A, E) and convalescent (B, F) stage of disease, one patient with ETEC infection at acute stage (C, G) and one healthy
control (D, H). I and J show the technical positive and negative control when staining of duodenal mucosa of the patient with V. cholerae O1 infection at the
acute stage with a probe for U6 small nuclear RNA (I) and a scrambled microRNA-probe (J). Original magnification: ×400.
https://doi.org/10.1371/journal.pone.0173817.g003
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Fig 4. Expression levels of target genes for miR-146a show only marginal differences between the acute and the convalescent stage of disease
in patients with V. cholerae O1 infection. Expression levels of IRAK1, TRAF6 and CARD10 mRNAs were determined in duodenal biopsies collected at
acute stage (Acute) and at the convalescent stage (Convalescent) of disease caused by V. cholerae O1 infection. Expression levels were determined by a
real-time qRT-PCR and normalized to the content of 18S rRNA in the sample. Results are shown as relative quantity (RQ) calculated by using the 2(-ΔΔct)-
method and the median Δct-value at convalescent stage as reference. Each point represents the value of an individual patient at the indicated disease
stage. Lines connect the values at acute and convalescent stage of the same patient.
https://doi.org/10.1371/journal.pone.0173817.g004
Table 1. Relative expression levels of mRNAs for miR-146a target genes, chemokines and inflamma-
tory cytokines in duodenal biopsies at acute compared to convalescent stage of disease in patients
with Vibrio cholerae O1 infection.
mRNA species Relative quantity at acute stage (RQ)* P-value#
miR-146a targets
IRAK1 0.87 (0.76–1.70)˚ >0.99
TRAF6 0.69 (0.46–0.85) 0.44
CARD10 0.62 (0.54–1.24) 0.44
Inflammasome cytokines
IL-1β 4.17 (2.07–15.38) 0.06
IL-18 1.00 (0.57–2.61) >0.99
Chemokines
IL-8/CXCL8 5.1 (4.41–6.09) 0.03
CXCL9 10.27 (2.60–49.92) 0.06
CXCL10 1.30 (0.24–6.12) 0.69
CXCL11 1.19 (0.47–7.21) 0.22
CX3CL1 0.98 (0.55–3.63) 0.84
Pro-inflammatory cytokines expressed in epithelial cells and macrophages
TNF-α 0.84 (0.50–2.86) 0.69
IL-6 1.44 (0.75–7.58) 0.31
Pro-inflammatory cytokines expressed in lymphocytes
IL-17A 1.54 (0.92–8.34) 0.44
IFN-γ 1.07 (0.39–4.07) 0.84
* RQ, relative quantity: RQ was calculated as the ratio between the level in the samples at acute stage and
the median level of the same mRNA species in the samples at the convalescent stage using the 2-ΔΔct-
method. Paired biopsies from 6 patients at the acute and the convalescent stage of disease were analyzed.
# P-value: The P-values were obtained by pairwise comparison of Δct-values at acute and convalescent
state of disease using two-sided Wilcoxon test.
˚ Median and interquartile range (IQR) from the 25th to the 75th percentile.
https://doi.org/10.1371/journal.pone.0173817.t001
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analyzed in the paired duodenal biopsies of the six V. cholerae O1 infected patients at acute
and convalescent stage of disease. Out of the 11 evaluated cytokines only 3, i.e. IL-1β, IL-8 and
CXCL9, showed highly increased expression levels in biopsies collected at acute stage of infec-
tion when compared to biopsies collected at the convalescent stage (Table 1 and Fig 5). IL-8
had a higher expression level in all six patients at the acute stage although the difference was
only marginal in two patients (Table 2 and Fig 5). Levels of CXCL9 mRNA were also higher at
the acute stage (Table 1 and Fig 5) followed by a reduced expression level at the convalescent
stage in all but one patient (Table 2 and Fig 5). The other 3 chemokines were expressed at low
levels and their expression levels were not increased at the acute stage of disease (Table 1 and
S1 Table). The average expression level of IL-1β mRNA was higher at the acute stage compared
to the convalescent stage and was decreased at convalescent stage in five out of six patients
(Tables 1 and 2 and Fig 5). The acute stage of disease did not induce increased mRNA expres-
sion levels for the epithelial cell and macrophage derived cytokines TNF-α and IL-6 or for the
T lymphocyte derived cytokines IFN-γ and IL-17A (Table 1).
V. cholerae O1 bacteria induce increased expression levels of
microRNAs in intestinal epithelial cells while secreted products induce an
inflammatory response
To address the question whether the bacteria per se are the causative agent for the increased
microRNA levels seen in the intestinal epithelium during V. cholerae O1 infection we
Table 2. Changes in expression levels of mRNA for miR-146a target genes, chemokines IL-8 and CXCL9 and inflammasome cytokine IL-1β from
acute to convalescent stage of disease in patients with V. cholerae O1 infection.
mRNA levels for miR-146a target genes
Patient Code IRAK1 TRAF6 CARD10 Increased relative quantity (RQ) at convalescent stage *
VC08 ↑ ↑ ↑ 3/3
VC13 ↑ ↑ ↑ 3/3
VC14  ↑ ↑ 2/3
VC16   ↑ 1/3
VC10 ↓  ↓ 0/3
VC09 ↓ ↓ ↓ 0/3
Increased relative quantity (RQ) at convalescent stage˚ 2/6 3/6 4/6
mRNA levels for chemotactic and inflammasome cytokine genes
Patient Code IL-8 CXCL9 IL-1β Decreased mRNA level at convalescent stage§
VC08 ↓ ↓ ↓ 3/3
VC13 ↓ ↑ ↓ 2/3
VC14 ↓ ↓ ↓ 3/3
VC16  ↓ ↑ 1/3
VC10 ↓ ↓ ↓ 3/3
VC09  ↓ ↓ 2/3
Decreased relative quantity (RQ) at convalescent stage# 4/6 5/6 5/6
↑Increased RQ from acute to convalescent stage of disease.
↓Decreased RQ from acute to convalescent stage of disease.
Marginal change in RQ from acute to convalescent stage of disease.
* Number of genes with increased mRNA level at convalescent stage/number of genes analyzed.
˚ Number of patients with increased mRNA level for the indicated gene/number of patients analyzed.
§ Number of genes with decreased mRNA level at convalescent stage/number of genes analyzed.
# Number of patients with decreased mRNA level for the indicated gene/number of patients analyzed.
https://doi.org/10.1371/journal.pone.0173817.t002
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performed challenge experiments of polarized tight monolayers of the human colon carci-
noma cell line T84. V. cholerae O1 isolates from two of the patients included in this study,
patient-codes VC08 and VC09, as well as the wild-type of V. cholerae O1 strain C6706 were
used for the challenge experiments. Bacteria and culture supernatants were applied at the api-
cal side in order to mimic the conditions during intestinal infection in the patients.
Challenge with live bacteria, of both the clinical isolates and the C6706 wild-type strain,
induced expression microRNAs in the polarized epithelial cells. Similarly, bacteria that had
been grown in LB broth, i.e. the growth conditions under which both V. cholera protease V
(PrtV) and cytolysin (VCC) are produced [24, 25], induced all three microRNAs tested. The
wild type C6706 strain induced statistically significant increased expression levels of all three
microRNAs, while the clinical strains VC08 and VC09 induced significant increase of miR-
155 levels (Fig 6, upper row). The latter two strains also induced increased levels of miR-146a
although the values did not reach statistical significance (Fig 6, upper row; P>0.05). Bacteria
that had been grown in AKI broth, i.e. growth conditions under which cholera toxin (CT) is
produced (S1 Fig) [26] induced only miR-375 (S2 Fig, upper row). In contrast to the results
obtained with live bacteria, culture supernatants collected from the three V. cholerae O1 strains
grown in either LB or AKI broth did not cause significant changes in microRNA levels in the
tight monolayer cells (Fig 6, lower row and S2 Fig, lower row). Next, we analyzed the mRNA
expression levels of the microRNA target genes IRAK1 and CARD10 after challenge with bac-
teria grown in LB. TRAF6 was not included since this mRNA species is barely detected in T84
monolayer cells (S2 File) and hence it would not be possible to detect a further down-regula-
tion. Only the live bacteria of the VC08 strain caused statistically significant reduction of
IRAK1 mRNA levels (Fig 7, upper row). Whole bacteria of the same strain did induce signifi-
cant increase of only one microRNA species, namely miR-155 (Fig 6, upper row). In contrast,
and somewhat unexpected, LB culture supernatants from the VC08 strain caused significant
increase in IRAK1 mRNA levels (Fig 7, lower row). In line with this, LB culture supernatants
from the three bacterial strains all caused significant increase in levels of CARD10 mRNA
Fig 5. Expression levels of IL-8 mRNA follow disease activity in patients with V. cholerae O1 infection. Expression levels of IL-8, CXCL9 and IL-1β
mRNAs were determined in duodenal biopsies collected at acute stage (Acute) and at the convalescent stage (Convalescent) of disease caused by V.
cholerae O1 infection. The mRNA expression levels were determined by a real-time qRT-PCR and normalized to the content of 18S rRNA in the sample.
Results are shown as mRNA copies/18S rRNA U for IL-8 and relative quantity (RQ) calculated by using the 2(-ΔΔct)-method and the median Δct-value at
convalescent stage as reference for CXCL9 and IL-1β. Each point represents the value of an individual patient at the indicated disease stage. Lines
connect the values at acute and convalescent stage of the same patient. Significance of differences between Δct-values at acute and convalescent stage
was analyzed using two-sided Wilcoxon’s non-parametric test for paired samples and P-values are given in the graph.
https://doi.org/10.1371/journal.pone.0173817.g005
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(Fig 7, lower row). Another unexpected finding was that challenge with live bacteria did not
cause any inflammatory response monitored as increased expression levels of IL-1β, CXCL9
and IL-8 (Fig 7). In contrast, culture supernatants from all three strains cause significant
increases in expression levels of mRNA for all three cytokines (Fig 7, lower row).
Discussion
In the present study we identified the increased expression of miR-146a and miR-155 in a
major population of epithelial cells and in scattered cells, presumably immune cells, in the lam-
ina propria of duodenal mucosa in patients at the acute stage of V. cholerae O1 infection, while
these microRNAs were not induced by ETEC infection. Furthermore, we show that V. cholerae
O1 bacteria, including clinical isolates from patients that we demonstrated increased micro-
RNA expression in the duodenal epithelium, induced an increased expression of miR-146a,
miR-155 and miR-375 in T84 polarized tight monolayer cells, suggesting that V. cholerae O1
bacteria can indeed be the cause of the increased levels of miR-146a and miR-155 in the epithe-
lium of the infected patients. To the best of our knowledge this is the first time that increased
levels of miR-146a and miR-155 have been demonstrated in the small intestinal mucosa of V.
cholerae O1 infected patients and the first time that V. cholerae O1 bacteria have been shown
Fig 6. V. cholerae O1 bacteria, but not their secreted products, induce increased expression of microRNAs in T84 polarized tight monolayer
cells. Tight monolayers of polarized T84 cells were challenged at the apical side with 105 bacteria of the V. cholerae O1 wild type strain C6706 and two V.
cholerae O1 clinical isolates, one from patient VC08 (VC08) and one from patient VC09 (VC09), that had been grown in LB broth overnight (upper row) or
with culture supernatants from overnight cultures of the same bacterial strains in LB (lower row). Levels of miR-146a, miR-155 and miR-375 were
determined by real-time qRT-PCR and expressed as relative quantity (RQ) compared to the median Δct of tight monolayers incubated in parallel to
challenged monolayers with tissue culture medium without added bacteria (Ctr, upper row) or fresh LB (Ctr, lower row). Bars indicate mean RQ + 1 SD of 4
tight monolayers for each challenge in the upper row and 3 in the lower row. Statistically significant differences from the control monolayers as determined
by one-way ANOVA with Dunett’s compensation for multiple comparisons, are shown. ** P-value <0.01, ***P-value <0.001.
https://doi.org/10.1371/journal.pone.0173817.g006
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to cause increased levels of these microRNAs in intestinal epithelial cells. Whether the differ-
ence between V. cholerae O1 and ETEC infected patients is due to different properties of the
two bacterial species or merely is a consequence of a small sample size in the ETEC group
(n = 4) remains to be elucidated.
V. cholerae O1 bacteria caused increased levels of miR-375 in T84 tight monolayer cells, yet
the miR-375 levels were not increased in the duodenal mucosa of the V. cholerae O1 infected
patients. This discrepancy might, at least in part, reflect organ-specific differences between epi-
thelial cells in small and large intestine since T84 cells originate from colonic epithelium.
There are however, additional factors that could contribute to differences in microRNA
expression in the duodenal mucosa of patients and the T84 tight monolayers, which can be dif-
ficult to accurately mimic in an in vitro model. Firstly, the time during which the epithelium is
exposed to bacteria and their factors, days in vivo in the patients compared to a merely 5 hours
co-culture in the in vitro model. Secondly, the duodenal mucosa is rich in immune cells and
inflammatory mediators such as cytokines and chemokines secreted by them might influence
the function(s) of the epithelial cells and their readiness to modulate microRNA expression
levels. Immune cells are not present in the in vitro model. Thirdly, the bacteria might differ in
their capacity to induce microRNA expression due to properties regulated by their environ-
ment. Thus, we found that the same V. cholerae O1 bacterial strains induced different micro-
RNAs depending on which broth they were grown in, i.e. mainly miR-155 was observed after
growth in LB broth, in which the bacteria secrete both VCC and PrtV and mainly miR-375
induction was observed after growth in AKI broth, which promotes CT secretion. How the
environment at the epithelial lining of the patients with acute cholera is influencing the capac-
ity of V. cholerae O1 bacteria to induce different microRNAs is currently unknown.
While miR-146a and miR-155 tend to shutdown innate immunity, miR-375 promotes the
differentiation of intestinal epithelial cells into goblet cells [23], which is also an important arm
of the innate immune defence. By increasing the proportion of goblet cells with consequent
increased production of mucus the mucosa might be protected by preventing bacteria from
Fig 7. Secreted products of V. cholerae O1 bacteria induce increased expression of genes involved in inflammation in T84 polarized tight
monolayer cells while live bacteria do not. The same RNA samples that were analyzed for miRNA expression levels (results shown in Fig 6) were also
analyzed for expression levels of mRNAs for the microRNA target genes IRAK1 and CARD10, the inflammasome cytokine IL-1β and the chemokines
CXCL9 and IL-8. The mRNA expression levels were determined by a real-time qRT-PCR and normalized to the content of 18S rRNA in the sample.
Results are shown as relative quantity (RQ) calculated by using the 2(-ΔΔct)-method and using the median Δct-value of the sham-treated controls as
reference for IRAK1, CARD10, IL-1β and CXCL9 and as mRNA copies/18S rRNA U for IL-8. Bars indicate mean + 1 SD (n = 4 in upper row and n = 3 in
lower row). Statistically significant differences from the sham-treated control monolayers as determined by one-way ANOVA with Dunett’s compensation
for multiple comparisons, are shown. * P-value <0.05; ** P-value <0.01; ***P-value <0.001; ****P-value <0.0001.
https://doi.org/10.1371/journal.pone.0173817.g007
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reaching the epithelial cell surface. In the colon the proportion of goblet cells in the epithelium
is higher, the mucosal layer is thicker and the bacterial load is much larger than in the small
intestine. This might be an as to explanation for why T84 cells with colonic origin are prone to
increase levels of miR-375.
The expression of IRAK1 and TRAF6 was only down-regulated in 2 and 3 out of 6 cholera
patients at the acute stage of disease although miR-146a and miR-155 were expressed at high
levels. This apparently contradictory result was also seen in rheumatoid arthritis. Elevated lev-
els of miR-146a was found in synovial fibroblast and blood mononuclear cells of rheumatoid
arthritis patients while the levels of IRAK1 and TRAF6 mRNAs were similar to those of con-
trols [18, 27]. The counteracting effects, anti-inflammatory from the bacteria themselves and
pro-inflammatory from their secreted products, may be the explanation for the unchanged lev-
els of IRAK1 and TRAF6 mRNAs in patients with acute V. cholerae infection.
The increased expression levels of IL-8, IL-1β and CXCL9 mRNAs in the duodenal mucosa
at the acute stage of disease suggest an on-going local inflammation in the small intestine.
However, the magnitude of this inflammatory response was rather weak when estimated as
cytokine mRNA levels at acute compared to convalescent stage. The elevated levels of the neu-
trophil chemoattractant IL-8 at acute stage is consistent with previous findings of larger
amounts of IL-8 secreted by lamina propria cells and accumulation of neutrophils in the duo-
denal mucosa at the acute phase [6, 28]. Elevated levels of IL-8 are also in agreement with
increased production of IL-8 by tight monolayers of epithelial cells after challenge with culture
supernatant of V. cholerae O1 bacteria [24, 25]. However, challenge of polarized tight mono-
layers with whole V. cholerae O1 bacteria failed to induce increased levels of IL-8. Instead chal-
lenge with bacteria applied at the side from which they would have attacked in vivo, induced
significant increases in both miR-146a and miR-155 levels. Taken together these data suggest
that the epithelium receives contradictory signals from the bacteria during infection meaning
pro-inflammatory from secreted factors and inflammation-limiting from the bacterial cells.
The variation in magnitude of inflammatory response between individuals might reflect the
outcome from differences in amount and composition of factors secreted by the bacteria and
differences in the mucus barrier function of the patient yielding varying degree of access of the
bacteria to the epithelial surface.
Levels of the lymphocyte and monocyte chemoattractant CXCL9 and the inflammasome-
activated cytokine IL-1β were higher at acute stage compared to the convalescent stage
(P = 0.06), but the response was relatively weak. This latter finding is in line with the proposed
down-regulatory role of miR-146a and miR-155 on inflammation and cytokine production [8,
18, 20, 29] and suggests that these microRNAs indeed limit the inflammatory response to V.
cholerae O1 bacteria during infection. In agreement with this, H. pylori infection up-regulates
the levels of miR-146a and miR-155 and down-regulates of the pro-inflammatory cytokines
IL-8 and growth-related oncogene (GRO)-α in the human gastric mucosa [29, 30].
In the present study we did not see disease activity related changes in expression of TNF-α
and IL-6, for which the main cellular sources are monocytes/macrophages and epithelial cells.
These results are in apparent contradiction to previous analyses of lamina propria cells at the
protein level [6, 28].
Two T lymphocyte derived cytokines were also analyzed in this study, IFN-γ and IL-17A.
They were chosen because T-helper cells of individuals who had gained immunity through
natural infection produced these cytokines upon in vitro challenge with V. cholerae antigens
[28]. Furthermore, they are the dominating cytokines produced by T lymphocytes in the
inflamed small intestinal mucosa of patients with active celiac disease [31, 32]. The levels of
these T cell cytokines were low and no changes related to disease activity were observed. The
results on IL-17A are concordant with a previous study at the protein level [28]. Overall, these
Induction of microRNAs in duodenal mucosa at acute stage of cholera
PLOS ONE | https://doi.org/10.1371/journal.pone.0173817 March 20, 2017 11 / 20
results suggest that the immune response at acute stage of cholera is mainly innate and to a
large extent emanates from epithelial cells.
Taken together the results suggest that V. cholerae O1 secretes factor(s) that induce an
inflammatory response in intestinal epithelial cells and that the bacteria themselves have the
capacity to counteract this response by inducing microRNAs that limit the inflammatory
response thereby reducing the risk for the bacteria to be eliminated by the host. A possible sce-
nario for the events occurring at acute stage of V. cholera infection is outlined in Fig 8. At the
earliest stage of infection, bacteria distant from the epithelial surface release components that,
when reaching the epithelium enter into the cytoplasm of the epithelial cells and provoke an
inflammatory response via the NFκB-pathway. The response includes increased expression of
Fig 8. Hypothetical scenario of what is happening at the epithelial lining of the small intestine at the acute phase of V. cholerae infection. V.
cholerae is a Gram(-), flagellated bacterium that secretes several soluble factors, e.g. cholera toxin and V. cholerae cytolysin, and release outer-
membrane vesicles (OMVs). The released components are all potential inducers of inflammatory responses. We hypothesize that the bacteria secrete
these factors already in the gut lumen. Their soluble nature makes it possible for them to pass through the mucous layer, reach the epithelial surface and
enter into the cytoplasm. The epithelial cells respond to this invasive attack by activating the IL-1β inflammasome and secretion of chemokines recruiting
immune cells to the site, notably IL-8 a strong attractant for neutrophil granulocytes (A). The Vibrio cholerae bacterium is motile and can produce
mucinases, hence it would be feasible for the bacteria to penetrate the mucous layer and reach the surface of the epithelial cells, although this process
would be slower than for the released factors. Thus, the bacterium reaches the epithelium with an ongoing innate immune response. By binding to
receptors at the cell surface the bacterium induces increased expression of microRNAs miR-146a and miR-155, thereby decreasing levels of IRAK1 with a
consequent decreased inflammatory activity and decreased risk for the bacterium to be eliminated and increasing its chances to thrive at the epithelial
lining and even get access to the bodily tissues (B). Figure adapted from: J Zhong, J-F Xu, P Yang, Y Liang, C-Y Wang (2011). Innate Immunity in the
Recognition of β-Cell Antigens in Type 1 Diabetes, Type 1 Diabetes—Pathogenesis, Genetics and Immunotherapy, Prof. David Wagner (Ed.), ISBN: 978-
953-307-362-0, InTech.
https://doi.org/10.1371/journal.pone.0173817.g008
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the mediators IRAK1 and CARD10, and induction of pro-inflammatory chemokines and cyto-
kines such as IL-8, CXCL9 and IL-1β (Fig 8A). Previous studies have shown that both soluble
factors and outer membrane vesicles released by V. cholerae can cause activation of NFκB and
production of pro-inflammatory cytokines [25, 33, 34]. At a later stage (Fig 8B), when the bac-
terium itself has passed the mucous layer and reached the epithelium it might bind to recep-
tors, e.g. TLRs, at the cell surface causing intracellular signaling with consequent increased
levels of miR-146a causing decreased levels of target genes such as IRAK1 and subsequent
shut-down of inflammation including the cessation of chemokine IL-8 and CXCL9 production
leading to reduced recruitment of immune cells to the infected site. This study suggest that V.
cholerae O1 has captured part of the host mechanism for ending an innate immune reaction of
the epithelium by acquiring the capacity to induce increased levels of the inflammatory regula-
tors miR-146a and miR-155. It is tempting to speculate that enteropathogens that have this
capacity can cause more severe disease than those who do not. The nature of these factor(s)
remains to be elucidated.
Materials and methods
Study groups and sample collection
Ten adult male patients, aged 22–46 years, with culture confirmed V. cholerae O1 (n = 6) and
ETEC (n = 4) infection were included in the study. Paired duodenal biopsies from the 2nd part
of the duodenum were collected from each patient at the acute stage (day 2 post-onset of dis-
ease) and at the convalescent stage (day 21 post-onset of disease) of infection by using a stan-
dard endoscope (Olympus, Tokyo, Japan). Duodenal biopsies were also collected from healthy
adults, defined as individuals who did not have a history of diarrheal illness in the previous 3
months (n = 5). Biopsies were directly stored in Trizol (Invitrogen Life Technologies, Carls-
bad, CA, USA) for analysis of mRNAs and microRNAs by real-time quantitative reverse tran-
scriptase-polymerase chain reaction (qRT-PCR) and also embedded in Optimal cutting
temperature compound (OCT-Tissue-Tek; Miles, Elkhart, IN, USA) for in situ hybridization.
All patients enrolled in this study were admitted to International Centre for Diarrheal Diseases
Research, Bangladesh (iccdr,b) with moderate to severe degree of dehydration. The ethical
review committee of iccdr,b approved the study. All participants gave their written informed
consent to participate in the study.
Bacterial strains
V. cholerae O1, El Tor, Inaba strain C6706, and V. cholerae O1, Ogawa, strains isolated at diag-
nosis [7] from the patients with codes VC08 and VC09. Strains were frozen and stored at
-80˚C in Luria-Bertani (LB) broth containing 15% glycerol. For polarized tight monolayer
challenge experiments, the bacteria were grown overnight at 37˚C with shaking in 10 mL of LB
or AKI broth. Bacterial cells were harvested by centrifugation at 14,000 rpm for 3 min at 4˚C.
The pellets were re-suspended in 1 mL tissue culture medium and the supernatants were sterile
filtered through a 0.22-μm PVDF membrane filter (Millipore, Merck Chemicals and Life Sci-
ence, Solna, Sweden).
Culture of T84 cells and establishment of polarized tight monolayers
The established colon carcinoma cell line T84 (American Type Culture Collection, Rockville,
MD, USA) was cultured at 37˚C in a humidified atmosphere with 5% CO2. Tissue culture
medium used was a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12
medium supplemented with 15 mM HEPES buffer, 8% fetal calf serum, 2 mM L-glutamine,
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100 units (U)/mL penicillin and 85μg/mL streptomycin. All tissue culture media components
were from Invitrogen (Paisley, UK). Confluent cultures were trypsinized by incubation for 5
min at 37˚C with 0.25% trypsin and 0.5% EDTA in phosphate buffered saline (PBS; pH 7.2).
After trypsinization cells were allowed to recover for 60 min at 37˚C in complete medium.
Tight monolayers were established by seeding 0.5×106 T84 cells in 0.5 mL complete culture
medium per well in transwell inserts with semi-permeable polycarbonate membrane supports
with 12 mm diameter and 0.4 μm pore size (Costar 3401; Corning Incorporated, Corning, NY,
USA). Complete culture medium (1.5 mL) was also added to the outside of the inserts. From
the second day after seeding, medium was changed every day until a confluent monolayer with
a transepithelial electrical resistance of 700 Ohm/cm2 was obtained [35]. Transepithelial
electrical resistance was measured by using the Millicell Electrical Resistance System (Milli-
pore) with chopstick electrodes.
Challenges with whole bacteria and bacterial products were done from the apical side of the
polarized tight monolayers. Tissue culture medium in the upper chamber was replaced by
either 0.5 mL of culture supernatant obtained from overnight culture of V. cholerae O1 strain
C6706 and two clinical isolates V. cholerae O1 from patients participating in this study, VC08
and VC09, in LB or AKI broth or 0.5 mL tissue culture medium containing 105 bacteria. Bacte-
ria had grown overnight in LB or AKI and were thereafter retrieved by centrifugation. Tight
monolayers to which fresh LB, fresh AKI, or tissue culture medium had been added to the api-
cal side served as controls. Challenged tight monolayers and control tight monolayers were set
up in triplicates or quadruplicates and were incubated in parallel for 5 hours at 37˚C in humid-
ified atmosphere with 5% CO2. Finally the membranes with tight monolayers were cut out,
washed 2 times with RNase-free PBS, frozen in 700 μL RLT buffer (pH 7.0) of the RNeasy
Mini Kit (Qiagen Valencia, CA, USA) with 1% 2-mercaptoethanol added and kept at -80˚C
until RNA extraction.
RNA extraction
Total RNA was extracted from Trizol preserved biopsy samples according to manufacturer’s
instructions (Invitrogen) and purified on RNeasy columns (Qiagen) [36]. Possible contaminat-
ing genomic DNA was removed by DNase I treatment [36].
Total RNA was extracted from T84 tight monolayers frozen in RTL buffer with 1% 2-mer-
captoethanol by using the RNeasy Mini Kit (Qiagen) and dissolved in RNase-free water.
RNase inhibitor, recombinant RNasin (1000 U/mL; Promega, Madison, WI, USA), was added
to each sample and samples were stored at -80˚C [37].
Determination of expression levels of microRNAs by using real-time
qRT-PCR
Expression levels of microRNAs miR-146a, miR-155 and miR-375, and small nuclear RNA
RNU48 were determined by real-time qRT-PCR using the TaqMan MicroRNA Reverse Tran-
scription (RT) Kit and TaqMan MicroRNA (TM) Assay primers for human miR-146a (hsa
miR-146a: 000468), miR-155 (hsa-miR-155: 002623), miR-375 (hsa-miR-375: 000564), and
RNU48 (RNU48: 001006) (Life Technologies, Foster City, CA, USA). RNA concentration was
determined by measuring optical density (OD) at 260 nm and purity checked as the OD260/
OD280 ratio where ratios above 1.95 were accepted (Nanodrop spectrophotometer). Ten ng
RNA was used for each sample in each real-time qRT-PCR reaction. The samples were ana-
lyzed in duplicates using the ABI prism 7900 HT sequence detection system (Applied Biosys-
tems, Foster City, CA). Expression levels were estimated by calculating the relative quantity
(RQ) by using the 2(-ΔΔct)-method [38]. The levels of microRNAs were normalized to RNU48
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by calculating the Δct between the ct-value of the microRNA species and the ct-value of the
RNU species in the same sample. ΔΔct was thereafter calculated as the microRNA/RNU Δct-
value in the sample minus the median microRNA/RNU Δct-value of either the healthy control
group or the patient group with V. cholerae infection at convalescent stage and in the case of
tight monolayers the Δct-value in the sample minus the median microRNA/RNU Δct-value of
control T84 tight monolayers sham-treated in parallel to tight monolayers challenged with V.
cholerae O1 bacteria or their secreted products.
Determination of expression levels of target-gene, cytokine and
chemokine mRNAs by using real-time qRT-PCR
Quantification of IL-8/CXCL8, CX3CL1, TNF-α, IL-6, IL-17A, and IFN-γ mRNAs was per-
formed using real-time qRT-PCR assays developed in the laboratory at Immunology, Umeå
University. The assays are based on the EZ-technology, with primers placed in different exons,
a reporter dye marked probe placed over the exon boundary in the amplicon and use of an
RNA copy standard. For details of the IL-8/CXCL8 and IL-6 assays see Ou et al. [35], the TNF-
α and IFN-γ assays Forsberg et al. [31], the IL-17A assay West et al. [39] and the CX3CL1 assay
Sjo¨berg et al. [40]. Results are given as mRNA copies/μl. Quantification of IRAK1, TRAF6,
CARD10, IL-1β, IL-18, CXCL9, CXCL10, and CXCL11, mRNAs was performed using the
Taqman gene Expression Assays Hs01018347_m1, Hs00377558_m1, Hs00367225_m1,
Hs00174097_m1, Hs_01038788_m1, Hs00970538_m1, Hs00171042_m1, and Hs00171138_m1,
respectively (Applied Biosystems). The concentration of 18S rRNA was determined in each
sample using real-time qRT-PCR (Applied Biosystems) and expressed as arbitrary units from a
standard curve of serial dilutions of a preparation of total RNA from human peripheral blood
mononuclear cells. One U was defined as the amount of 18S rRNA in 1 pg of RNA, and corre-
sponds to approximately 1 epithelial cell [41]. All samples included in the study contained >16
U 18S rRNA per reaction mixture.
Samples were analyzed in triplicates using the ABI prism 7900 HT sequence detection sys-
tem (Applied Biosystems). mRNA concentrations were normalized to the18S rRNA concen-
tration in the sample by calculating mRNA copies/18S rRNA unit for mRNAs analyzed by
assays with an RNA copy standard and by calculating the Δct between the ct-value for the
mRNA species and the ct-value for 18S rRNA (ctsample−ct18S rRNA) for mRNAs analyzed by
commercial Taqman gene Expression Assays. Since there is no standard for the Taqman gene
Expression Assays result from these analyses are given as relative quantity (RQ) calculated by
the 2(-ΔΔct)-method where ΔΔct is Δct for the sample minus the median of the Δct-values of the
patient group with V. cholerae infection at convalescent stage or control T84 tight monolayers
sham-treated in parallel to monolayers challenged with V. cholerae bacteria or their secreted
factors.
In situ microRNA hybridization
In situ hybridization was performed on 12 μm thick cryostat sections on SuperFrost Plus glass
slides (Thermo Fisher Scientific Gerhard Menzel, Braunschweig, Germany) obtained from duo-
denal biopsies and fixed in 4% paraformaldehyde. Digoxigenin (Dig)-labeled miRCURY locked
nucleic acid (LNA) microRNA detection probes from Exiqon (Vedbaek, Denmark) were used
for the detection of microRNAs in the duodenal mucosa. The probes used were the miR-146a
complementary probe hsa-miR-146a (sequence: /5DigN/AACCCATGGAATTCAGTTCTCA/
2Dig_N/), the miR-155 complementary probe hsa-miR-155 (sequence: /5DigN/ACCCCTATCA
CGATTAGCATTAA/3Dig_N/), the RNU6 complementary probe hsammurno (positive control,
sequence: /5DigN/ACCCCTATCACGATTAGCATTAA/3Dig_N/), and Scramble-miR (negative
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control, sequence: /5DigN/GTGTAACACGTCTATACGCCCA/3Dig_N/). The probes were diluted
in hybridization solution [500 mL Formamide, 200 mL 20xSSC, 50 mL of 20×Denhardt’s solu-
tion, 50 mL of denatured herring sperm DNA (10mg/ mL), 25 mL Bakers yeast RNA (10 mg/
mL) and 175 mL of 50% Dextran sulfate]. Tissue sections were incubated with diluted probes
overnight at 60˚C in a humid chamber. After hybridization bound probes were revealed by
incubation with alkaline phosphatase conjugated Fab-fragments of anti-Dig antibodies (Roche,
Mannheim, Germany) and subsequent color reaction was carried out by using the NBT/BCIP
reagent (Roche). Tissue sections were counterstained with methylgreen. Microscopic evaluation
was performed with a standard light microscope equipped with 3CCD camera (Hamamatsu
photonics, Hamamatsu City, Japan). Leica QWin software (Leica Imaging System, Cambridge,
UK) was used for image acquisition.
Statistical analyses
Descriptive data are expressed as median values with the 25th and 75th percentiles, interquartile
range (IQR) for analyses performed on clinical material and mean ± 1 standard deviation (SD)
for tight monolayer experiments. Statistical analyses on changes in microRNA and mRNA
expression levels were performed using the normalized microRNA and mRNA amounts
obtained by calculating the Δct-values between ct-values of microRNA species under investiga-
tion and the ct-value for RNA48 in the same sample and between the ct-value of the mRNA
species under investigation and the ct-value of 18S rRNA in the same sample, respectively. Sta-
tistical analysis was performed comparing expression levels as mRNA copies/18S rRNA U for
mRNAs for which a qRT-PCR assay with mRNA copy standard was available. Statistical analy-
sis of differences in microRNA and mRNA levels in samples from acute and convalescent
stage of V. cholerae infection was performed using the paired, non-parametric Wilcoxon t-test.
Comparisons between microRNA levels between more than two data sets from analysis of
patient material was performed using Kruskal-Wallis’ nonparametric one-way analysis of vari-
ance (ANOVA) with Dunn’s multiple comparisons post-test. Correlation analysis comparing
miR-146a and miR-155 levels in biopsies were was performed using Spearman correlation
analysis test. Statistical analysis of differences in microRNA and mRNA levels in polarized
tight monolayers challenged with V. cholerae bacterial strains or their secreted products, was
performed using ordinary one-way ANOVA with Dunett’s multiple comparison post-test. Sta-
tistical analyses were performed using the Prism 5 computer program (GraphPad Software,
San Diego, CA, USA). Two-sided analysis was used throughout. A P-value<0.05 was regarded
as statistically significant.
Supporting information
S1 Fig. Vibrio cholerae O1 bacteria clinical isolates VC08 and VC09 secrete both Cholera
Toxin (CT) and V. Cholerae Cytolysin (VCC) when grown in AKI broth. Western-blot
analyses to detect V. cholerae cholera toxin (CT) (a, c) or V. cholerae cytolysin (VCC) (b, d) in
overnight culture supernatants of the wild-type V. cholerae O1 strain C6706 (C6706/WT),
V. cholerae O1 strain C6706 CT deletion mutant (C6706/ΔCT), V. cholerae O1 strain C6706
VCC deletion mutant (C6706/ΔVCC) and two V. cholerae O1 clinical isolates, one from patient
VC08 (VC08) and one from patient VC09 (VC09), that had been grown in AKI broth over-
night. (a) and (b) show Western-blots using anti-CT and anti-VCC antibodies, respectively.
(c) and (d) show semiquantitative analyses of CT (c) and VCC (d) protein levels obtained from
chemiluminescence analysis of the same samples. Lane 1 and 5 (VC08); Lane 2 and 6 (VC09);
Lane 3 and 8 (C6706/ΔCT); Lane 4 and 9 (C6706/WT); and Lane 7 (C6706/ΔVCC). The arrow
shows the immunoreaction bands of CT or VCC protein. The plotted data in (c) and (d) show
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relative protein levels of CT (c) and VCC (d) compared to the levels of the respective protein
in culture supernatant of the wild-type C6706 strain. Y-axis in (c) and (d) = relative level of
protein, with the level of the wild-type of the strain C6706 set to 1.0.
(TIF)
S2 Fig. Vibrio cholerae O1 bacteria, but not their secreted products, induce increased
expression of miR-375 microRNA in T84 polarized tight monolayer cells. Tight monolayers
of polarized T84 cells were challenged at the apical side with 105 bacteria of the V. cholerae O1
strain C6706 (C6706) and two V. cholerae O1 clinical isolates, one from patient VC08 (VC08)
and one from patient VC09 (VC09), that had been grown in AKI broth overnight (upper row)
or with culture supernatants from overnight cultures of the same bacterial strains in AKI
(lower row). Levels of miR-146a, miR-155 and miR-375 were determined by real-time qRT-
PCR and expressed as relative quantity (RQ) compared to the median Δct of tight monolayers
incubated in parallel to challenged monolayers with tissue culture medium without added
bacteria (Ctr, upper row) or fresh AKI (Ctr, lower row). Bars indicate mean RQ + 1 SD of 4
tight monolayers for each challenge in the upper row and 3 in the lower row. Statistically sig-
nificant differences from the control monolayers as determined by one-way ANOVA with
Dunett’s compensation for multiple comparisons, are shown.  P-value<0.05,  P-value
<0.01,  P-value <0.001.
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S1 Table. Expression levels of mRNAs for miR-146a target genes, chemokines and inflam-
matory cytokines in duodenal biopsies at acute compared to convalescent stage of disease
in patients with Vibrio cholerae O1 infection.
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